Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.

Jiang Z, Slater CM, Zhou Y, Devarajan K, Ruth KJ, Li Y, Cai KQ, Daly M, Chen X.

Breast Cancer Res. 2017 May 30;19(1):62. doi: 10.1186/s13058-017-0853-2.

2.

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.

Sun X, Zhangyuan G, Shi L, Wang Y, Sun B, Ding Q.

Medicine (Baltimore). 2017 May;96(19):e6860. doi: 10.1097/MD.0000000000006860. Review.

3.

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.

Koleck TA, Bender CM, Clark BZ, Ryan CM, Ghotkar P, Brufsky A, McAuliffe PF, Rastogi P, Sereika SM, Conley YP.

Breast Cancer (Dove Med Press). 2017 Mar 3;9:95-110. doi: 10.2147/BCTT.S123785. eCollection 2017.

4.

EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.

Han C, Liao X, Qin W, Yu L, Liu X, Chen G, Liu Z, Lu S, Chen Z, Su H, Zhu G, Lu Z, Liu Z, Qin X, Gui Y, Mo Z, Li L, Peng T.

Sci Rep. 2016 Aug 9;6:31237. doi: 10.1038/srep31237.

5.

Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Ohkoshi S, Yano M, Matsuda Y.

World J Gastroenterol. 2015 Nov 14;21(42):12150-6. doi: 10.3748/wjg.v21.i42.12150. Review.

6.

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Ip JC, Pang TC, Glover AR, Soon P, Zhao JT, Clarke S, Robinson BG, Gill AJ, Sidhu SB.

Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.

7.

Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.

Zhang W, Liu Y, Zhao N, Chen H, Qiao L, Zhao W, Chen JJ.

J Virol. 2015 Mar;89(5):2553-62. doi: 10.1128/JVI.02269-14. Epub 2014 Dec 17.

8.

Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.

Wettersten HI, Landesman Y, Friedlander S, Shacham S, Kauffman M, Weiss RH.

PLoS One. 2014 Dec 2;9(12):e113867. doi: 10.1371/journal.pone.0113867. eCollection 2014.

9.

Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.

Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D.

Breast Cancer Res Treat. 2012 Nov;136(1):129-42. doi: 10.1007/s10549-012-2246-7. Epub 2012 Sep 29.

10.

A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.

Dai M, Al-Odaini AA, Arakelian A, Rabbani SA, Ali S, Lebrun JJ.

Breast Cancer Res. 2012 Sep 20;14(5):R127. doi: 10.1186/bcr3322. Erratum in: Breast Cancer Res. 2017 Mar 28;19(1):40.

11.

Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress.

Hoeferlin LA, Oleinik NV, Krupenko NI, Krupenko SA.

Genes Cancer. 2011 Sep;2(9):889-99. doi: 10.1177/1947601911432495.

12.

Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck.

Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, Arnolds J, Bergmann C, Bas M, Lang S, Lehnerdt G, Brandau S, Mattheis S, Scheckenbach K, Finn OJ, Whiteside TL, Sonkoly E.

Anticancer Res. 2011 Oct;31(10):3151-7.

13.

Serum-nutrient starvation induces cell death mediated by Bax and Puma that is counteracted by p21 and unmasked by Bcl-x(L) inhibition.

Braun F, Bertin-Ciftci J, Gallouet AS, Millour J, Juin P.

PLoS One. 2011;6(8):e23577. doi: 10.1371/journal.pone.0023577. Epub 2011 Aug 24.

14.

Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.

Inoue H, Hwang SH, Wecksler AT, Hammock BD, Weiss RH.

Cancer Biol Ther. 2011 Nov 1;12(9):827-36. doi: 10.4161/cbt.12.9.17680. Epub 2011 Nov 1.

15.

CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET.

Dev Cell. 2010 Nov 16;19(5):753-64. doi: 10.1016/j.devcel.2010.10.013.

16.

Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity.

Matthess Y, Raab M, Sanhaji M, Lavrik IN, Strebhardt K.

Mol Cell Biol. 2010 Dec;30(24):5726-40. doi: 10.1128/MCB.00731-10. Epub 2010 Oct 11.

17.

Protein subcellular localization profiling of breast cancer cells by dissociable antibody microarray staining.

Fu G, Song XC, Yang X, Peng T, Wang Y, Zhou GW.

Proteomics. 2010 Apr;10(8):1536-44. doi: 10.1002/pmic.200900585.

18.

p21 in cancer: intricate networks and multiple activities.

Abbas T, Dutta A.

Nat Rev Cancer. 2009 Jun;9(6):400-14. doi: 10.1038/nrc2657. Review.

19.

High cyclin B1 expression is associated with poor survival in breast cancer.

Aaltonen K, Amini RM, Heikkilä P, Aittomäki K, Tamminen A, Nevanlinna H, Blomqvist C.

Br J Cancer. 2009 Apr 7;100(7):1055-60. doi: 10.1038/sj.bjc.6604874. Epub 2009 Mar 17.

20.

The cancer secretome: a reservoir of biomarkers.

Xue H, Lu B, Lai M.

J Transl Med. 2008 Sep 17;6:52. doi: 10.1186/1479-5876-6-52. Review.

Supplemental Content

Support Center